PARLIAMENTARY WRITTEN QUESTION
Hormone Replacement Therapy: Coronavirus (9 November 2020)

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve the availability of Hormone Replacement Therapy supplies during the November 2020 covid-19 lockdown in England.

Asked by:
Fleur Anderson (Labour)

As part of our concerted national efforts to respond to the pandemic, we are doing everything we can to ensure patients continue to access safe and effective medicines. We are aware of supply issues that have affected some hormone replacement therapy (HRT) preparations for various reasons, including regulatory or manufacturing issues and commercial decisions made by some companies to divest some products. While a very limited number of HRT products are currently affected, most, including alternatives to those experiencing supply issues are available.

We have been working closely with all suppliers of HRT medicines to maintain overall access to patients and have provided regular updates about these issues and management advice to the National Health Service. The overall situation has been improving since the end of February 2020 and will continue to improve in the coming months.

Answered by:
Jo Churchill (Conservative)
23 November 2020